PATOU GARY

SEC Form 4 insider trading activity

PATOU GARY has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.

On the most recent filing, PATOU GARY is listed as Director at Xenon Pharmaceuticals Inc. Inside the rolling window, PATOU GARY reported no open-market purchases and 1 open-market sale totaling $70K in XENE.

Companies traded

Other insiders at XENE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$70K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
XENE
PATOU GARY
Sale$70KJun 8SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has PATOU GARY made?

PATOU GARY has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does PATOU GARY trade?

PATOU GARY has filed SEC Form 4 disclosures for 1 company, including XENE.

When was PATOU GARY's most recent SEC Form 4 filing?

PATOU GARY's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.

What is PATOU GARY's total buy and sell value in the current window?

Inside the rolling retention window, PATOU GARY bought $0 and sold $70K based on SEC Form 4 filings.

What was PATOU GARY's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,322 XENE shares on 2026-06-05, worth $70K, per SEC Form 4 filings.